EUVIMEDExplore EUVIMED
EUVIMED · CrossrefJournal

Annals of Hematology

ISSN 0939-5555 · Springer Science and Business Media LLC

Latest articles

  1. VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML

    Lydia Kretschmer, Leo Ruhnke, Christoph Schliemann, Lars Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, Christoph Schmid, Maher Hanoun, Tim Sauer, Klaus H. Metzeler, Kerstin Schäfer-Eckart, Mathias Hänel, Martina Crysandt, Paul Jäger, Stefan W. Krause, Christine Dierks, Stefan Klein, Nadia Maguire, Lukas P. Frenzel, Veit L. Bücklein, Wolfgang Blau, Ulrich Kaiser, Kai Wegehenkel, Alexander Höllein, Ruth Seggewiss-Bernhardt, Wenke Markgraf, Frank Fiebig, Anna Harig, Katharina Schmidt-Brücken, Christian Thiede, Jan Moritz Middeke, Richard Dillon, Claudia D. Baldus, Hubert Serve, Karsten Spiekermann, Wolfgang Hiddemann, Richard F. Schlenk, Carsten Müller-Tidow, Martin Bornhäuser

    Published: 2025-07DOI: 10.1007/s00277-025-06496-7

Volumes

2026 · 12025 · 4312024 · 6752023 · 4342022 · 3942021 · 3872020 · 3872019 · 3702018 · 3202017 · 3142016 · 3262015 · 3402014 · 3292013 · 2762012 · 3012011 · 2432010 · 2322009 · 2192008 · 1892007 · 1452006 · 1932005 · 1822004 · 1702003 · 1862002 · 1692001 · 1982000 · 1311999 · 1101998 · 1111997 · 1061996 · 1421995 · 2241994 · 1591993 · 1321992 · 1411991 · 122

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.